Ongoing Use of Data and Specimens from NCI Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program

Por Minasian, Lori, Tangen, Catherine M., Wickerham, D. Lawrence
Publicado no Semin Oncol (2015)

Prostate-Specific Antigen: A Misused and Maligned Prostate Cancer Biomarker

Por Thompson, Ian M., Tangen, Catherine M., Kristal, Alan R.
Publicado em 2008

Prostate-Specific Antigen, Risk Factors, and Prostate Cancer: Confounders Nestled in an Enigma

Por Thompson, Ian M., Ankerst, Donna P., Tangen, Catherine M.
Publicado em 2010

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial

Por Thompson, Ian M, Tangen, Catherine M, Goodman, Phyllis J
Publicado em 2014

Prostate cancer screening second edition /

Por Ankerst, Donna Pauler, Tangen, Catherine M., Thompson Jr., Ian M.
Publicado em 2009

Failure to Achieve a Complete Response to Induction BCG Therapy is Associated with Increased Risk of Disease Worsening and Death in Patients with High Risk Non–Muscle Invasive Blad...

Por Lerner, Seth P., Tangen, Catherine M., Sucharew, Heidi, Wood, David, Crawford, E. David
Publicado em 2008

An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection

Por Vickers, Andrew J., Till, Cathee, Tangen, Catherine M., Lilja, Hans, Thompson, Ian M.
Publicado em 2011

PREDICTORS OF SURVIVAL IN ADVANCED RENAL CELL CARCINOMA: LONG-TERM RESULTS FROM SOUTHWEST ONCOLOGY GROUP TRIAL S8949

Por Lara, Primo N., Tangen, Catherine M., Conlon, Sarah, Flanigan, Robert C., Crawford, E. David
Publicado em 2008

Does the level of prostate cancer risk affect cancer prevention with finasteride?

Por Thompson, Ian M., Tangen, Catherine M., Parnes, Howard L., Lippman, Scott M., Coltman, Charles A.
Publicado em 2008

Predicting Risk of Prostate Cancer in Men Receiving Finasteride: Effect of Prostate Volume, Number of Biopsy Cores, and American Urological Association Symptom Score

Por Ankerst, Donna P., Till, Cathee, Boeck, Andreas, Goodman, Phyllis J., Tangen, Catherine M., Thompson, Ian M.
Publicado em 2013

Alcohol Consumption, Finasteride and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Por Gong, Zhihong, Kristal, Alan R., Schenk, Jeannette M., Tangen, Catherine M., Goodman, Phyllis J., Thompson, Ian M.
Publicado em 2009

Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials

Por Tangen, Catherine M., Goodman, Phyllis J., Till, Cathee, Schenk, Jeannette M., Lucia, M. Scott, Thompson, Ian M.
Publicado no J Clin Oncol (2016)

Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

Por Schenk, Jeannette M., Calip, Gregory S., Tangen, Catherine M., Goodman, Phyllis, Parsons, J. Kellogg, Thompson, Ian M., Kristal, Alan R.
Publicado em 2012

Retention of Black and White Participants in the Selenium and Vitamin E Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S0000)

Por Arnold, Kathryn B., Hermos, John, Anderson, Karen B., Minasian, Lori, Tangen, Catherine M., Probstfield, Jeffrey F., Cook, Elise D.
Publicado no Cancer Epidemiol Biomarkers Prev (2014)

Serum Adiponectin, C-peptide and Leptin and Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

Por Schenk, Jeannette M., Kristal, Alan R., Neuhouser, Marian L., Tangen, Catherine M., White, Emily, Lin, Daniel W., Thompson, Ian M.
Publicado em 2009

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Por Martinez, Erin E., Darke, Amy K., Tangen, Catherine M., Goodman, Phyllis J., Fowke, Jay H., Klein, Eric A., Abdulkadir, Sarki A.
Publicado em 2014

Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

Por Schenk, Jeannette M., Kristal, Alan R., Neuhouser, Marian L., Tangen, Catherine M., White, Emily, Lin, Daniel W., Kratz, Mario, Thompson, Ian M.
Publicado em 2010

Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT

Por Lotan, Yair, Goodman, Phyllis J., Youssef, Ramy F., Svatek, Robert S., Shariat, Shahrokh F., Tangen, Catherine M., Thompson, Ian M., Klein, Eric A.
Publicado no J Urol (2012)

Finasteride Does Not Increase the Risk of High-grade Prostate Cancer: A Bias-adjusted Modeling Approach

Por Redman, Mary W., Tangen, Catherine M., Goodman, Phyllis J., Parnes, Howard, Ford, Leslie G., Lucia, M. Scott, Coltman, Charles A., Thompson, Ian M.
Publicado em 2008

Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial

Por Schenk, Jeannette M., Kristal, Alan R., Arnold, Kathryn B., Tangen, Catherine M., Neuhouser, Marian L., Lin, Daniel W., White, Emily, Thompson, Ian M.
Publicado em 2011